LILLY ENDOWMENT INC

CIK 316011 · View on SEC EDGAR ↗

Portfolio value
$108.4B
#67 of 9,443 by 13F value · top 0.7%
Positions
1
As of
June 30, 2026

Portfolio value QoQ: +28.2% 13F does not disclose cash

Top 10 holdings weight
100.00%
Top 25 holdings weight
100.00%
Positions above 1%
1
Effective number of positions
1.0

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q2 2026: 0.0% Est. buys $0 · sells $1,823,133,600

Median holding: 7.0 quarters Tracked Q4 2024–Q2 2026 · 100.0% still held

New positions
0
Increased
0
Decreased
1
Closed
0
On this page

Performance vs S&P 500

Tracked Q4 2024–Q2 2026
+57.0%
S&P 500 total return (same window)
+28.1%
Excess return
+28.9%

Annualized: +35.2% · S&P 500: +18.0%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

Healthcare
100.0%

Full portfolio 1 positions

Type Streak 8Q trend
LLY Eli Lilly and Company Common Stock $108,400,858,723 100.00% 90,376,978 $23,876,775,268 Down ×4

Top movers (QoQ)

Security Action Shares Δ Value Δ
LLY Trimmed -1.5M +$23.9B